skip to main content
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

16 Total results for product and free and sample content found

HBW Insight

Germany's Supplements Market Boosted By COVID-19

27 Nov 2020

Coronavirus Pills

Infographic: COVID-19 delivers an 8% sales growth injection to Germany's supplements market in the first half of the year, accelerating a long-term expansion.

Topic Dietary Supplements Market Intelligence

HBW Insight

Covid-19 Disrupting Supply Chains Short-Term, Could Spark Long-Term Procurement Shifts

By Eileen Francis 27 Nov 2020

Covid19

UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.

Topic Coronavirus Cosmetics Dietary Supplements Distribution

HBW Insight

COVID-19 Concerns Could Enhance Ongoing Bloom Of Plant Based Sports Nutrition Sales

By Malcolm Spicer 29 Oct 2020

Covid19 Plant Based Diets

"One of the issues that COVID-19 has brought out is, how safe is the production of animal-based food products?" says Innova Market Insights North America executive Tom Vierhile at AHPA sports nutrition conference.

Topic Coronavirus Dietary Supplements Market Intelligence

HBW Insight

UK Trial Seeks 'Definitive Answer' In Vitamin D's Role For COVID-19 Protection

By Tom Gallen 21 Oct 2020

HBW Vitamin D Coronavirus

UK trial involving 5,000 participants "has the potential to give a definitive answer to the question of whether vitamin D offers protection against COVID-19," according to researchers.

Topic Coronavirus Clinical Trials Dietary Supplements

HBW Insight

Italy's Supplements Market Gets Big Boost From COVID After Solid 2019

By Tom Gallen 15 Jul 2020

hbw-italy-supplement

Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year.

Topic Coronavirus Dietary Supplements

HBW Insight

No Evidence That Vitamin D Prevents Or Treats COVID-19

By David Ridley 15 Jul 2020

hbw-vitamind

UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.

Topic Coronavirus Dietary Supplements

HBW Insight

Probiotics’ Efficacy Too Specific For General Look In ’60 Minutes’ Segment Critical Of Category

By Eileen Francis 15 Jul 2020

hbw-probiotics

Assertions that no convincing evidence supports that probiotics available in the US treat symptoms of diarrhea, irritable bowel syndrome or allergies look at the category as a whole and not individual strains shown to help with specific conditions, say consumer health industry groups.

Topic Coronavirus Dietary Supplements Research & Development

HBW Insight

US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC

By Malcolm Spicer 22 Jun 2020

us-covid-fraud

FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.

Topic Coronavirus Dietary Supplements

HBW Insight

CBD News Round-Up: Australia Proposes OTC Pathway, First EU Novel Food Validation, COVID Boost For UK Firm

By David Ridley 14 May 2020

cbd-news

Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.

Topic Dietary Supplements Coronavirus

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: